Our findings are of great importance for clarifying the clinical relevance of HLA-G2/6 and HLA-G1/4/5 expression in other cancers and for advancing precision HLA-G-targeted cancer immunotherapy for patients with solid tumors. Here, HLA-G is linked to cancer.